10 Questions to Ask Before Starting Any GLP-1 Compound
Before the pen touches skin, there are ten things worth knowing. This is how to ask them.
1 in 8
US adults now taking or have taken a GLP-1
67%
Of new users start without asking key safety questions
3Ã
More likely to stay on protocol when questions are answered first
GLP-1 compounds are not one-size-fits-all. Semaglutide, tirzepatide, liraglutide â each has a distinct profile, a different uptitration schedule, and a different relationship with your body. Most people get the pen, read the brand name, and start. But the people who do it right? They ask questions first.
"The most informed GLP-1 users are not the ones who read the most. They are the ones who asked the right things before they began."
Which compound is actually right for my goals?
Not all GLP-1s are built the same. Semaglutide targets GLP-1 receptors only. Tirzepatide hits both GLP-1 and GIP receptors â a dual agonist that tends to show stronger weight loss in trials. Liraglutide is shorter-acting and requires daily injections. Your goals, your health profile, and your tolerance for side effects should shape this answer, not a trend.
Ask your provider to walk you through both single and dual agonist options before deciding.
What is the uptitration schedule, and why does it matter?
GLP-1 compounds are not taken at full dose from week one. You climb. Slowly. Uptitration exists to let your GI system adapt â jumping too fast means nausea, vomiting, and early dropout. Understanding the schedule before you start is the difference between a 3-month trial and a 3-week abort.
Get the full titration calendar in writing. Week by week.
Dropout Rates by Month â When Do People Quit?
Cumulative discontinuation % by compound â most attrition happens in the first 90 days
- Semaglutide
- Tirzepatide
- Liraglutide
Based on published retention data from clinical trial and real-world cohorts. Illustrative; individual variation is significant.
Do I have any contraindications I might not know about?
Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 are formal contraindications for semaglutide and tirzepatide. Pancreatitis history also raises red flags. This is not a question to skip because you feel healthy.
Ask your provider to review your full family history, not just your current conditions.
How will this interact with my current medications?
GLP-1 compounds slow gastric emptying, which changes how other medications are absorbed. If you take oral contraceptives, thyroid medications, or antidiabetic drugs, your dosing timing may need to shift. This is not theoretical. It is a real mechanism with real consequences for bioavailability.
Bring a full medication list â including supplements â to your consultation.
Side Effect Landscape â Most Commonly Reported
% of users reporting each effect based on pooled clinical trial data
Nausea is the most common early effect â and the most preventable with proper uptitration and meal timing.
What does success actually look like at 12 weeks?
Expecting dramatic results in week two is a setup for disappointment. Clinical benchmarks suggest meaningful weight loss or metabolic change typically begins showing at 8 to 12 weeks for most people. Define your short-term markers before you start so you are measuring the right things.
Set a 12-week checkpoint goal with your provider, not a 2-week goal.
Am I a candidate for microdosing instead of standard dosing?
Microdosing â using doses substantially below clinical thresholds â has gained real traction. For some people, especially those with significant sensitivity to GI side effects or those using GLP-1s for longevity rather than acute weight loss, lower doses offer better tolerance and sustained adherence. It is worth the conversation.
Ask specifically: "Is a microdose protocol appropriate for my goals?"
Why People Choose Microdosing
Primary reasons cited by users who opted for below-threshold dosing protocols
What happens if I need to stop suddenly?
GLP-1 compounds suppress appetite through a hormonal mechanism. When that mechanism stops, appetite can return â sometimes sharply. Having a plan for what happens on the other side of the prescription is not pessimism. It is how you protect the progress you built.
Ask for a written discontinuation protocol before you start.
How will I track progress beyond the scale?
Weight is one marker. But metabolic panels, waist circumference, fasting glucose, blood pressure, and energy levels tell a fuller story. Many successful GLP-1 users report improvements in these areas before the number on the scale meaningfully moves. Tracking only weight is like watching one instrument on a dashboard.
Request a baseline metabolic panel before your first injection.
Compound Comparison â At a Glance
Quick reference before your first provider conversation
| Compound | Mechanism | Dosing | Avg weight loss (52 wk) | GI tolerance |
|---|---|---|---|---|
| Semaglutide | GLP-1 agonist | Weekly | ~15% | Moderate |
| Tirzepatide | GLP-1 + GIP dual | Weekly | ~22% | Moderate |
| Liraglutide | GLP-1 agonist | Daily | ~8% | Generally good |
| Retatrutide | GLP-1 + GIP + glucagon | Weekly | ~24% (trial) | More challenging |
What is the sourcing and quality of my compound?
With the growth of compounded GLP-1 medications, quality variance is real. FDA-approved formulations go through rigorous testing. Compounded versions may not. Ask specifically where your compound is sourced, whether the pharmacy is 503B-registered, and whether sterility testing documentation exists. Not a question to feel awkward about.
Request a certificate of analysis (COA) for any compounded preparation.
What does long-term use look like for me specifically?
GLP-1 therapy is increasingly viewed as long-term or even lifelong for many users. Understanding what the 2-year and 5-year version of your protocol looks like â including potential dose adjustments, monitoring requirements, and cost trajectory â helps you make a truly informed decision, not just a month-one decision.
Ask: "What does this look like for me in 3 years if things go well?"
Before Your Consultation: A Quick Checklist
- Full medication and supplement list ready
- Family history of thyroid or MEN2 conditions noted
- 12-week and 52-week goals defined
- Questions about microdosing prepared
- Sourcing documentation to request noted
- Baseline labs scheduled or requested
Frequently Asked Questions
Is it safe to start a GLP-1 without a provider?
GLP-1 compounds carry real contraindications and drug interactions. Starting without a qualified provider review â especially of your medication list and personal history â creates avoidable risk. Online prescribing platforms can be legitimate, but they should still involve a clinical review.
How long before I see real results?
Metabolic improvements (blood sugar, energy, hunger patterns) often start within the first few weeks. Measurable weight loss for most people begins showing at 8 to 12 weeks, with more significant changes at the 6-month mark. Patience in the first month is not a sign the protocol is failing.
Can I take a GLP-1 if I am not diabetic?
Yes. Semaglutide (as Wegovy) and tirzepatide (as Zepbound) are FDA-approved specifically for obesity management in non-diabetic adults meeting certain BMI thresholds. Many people also use compounded GLP-1s off-label for weight management and metabolic health outside these approvals.
What is a 503B compounding pharmacy?
503B facilities are FDA-registered outsourcing facilities for compounded medications. They are subject to higher quality standards than 503A pharmacies, including sterility testing and facility inspections. If you are using a compounded GLP-1, a 503B source is generally considered a higher-safety option.
Is microdosing a real protocol or a trend?
It is increasingly recognized as a legitimate clinical approach, particularly for individuals using GLP-1s for longevity purposes or those who cannot tolerate standard doses. While large randomized controlled trials are still emerging, growing provider-reported experience and observational data support its use in appropriate candidates.
Not sure which GLP-1 fits your profile?